Menu
Advanced Health & Human Advancement
This Alliance brings forward drug/vaccine technologies and treatments and an established body comprised of African & African-Diasporan based corporations, academic institutions, and NGOs involved in numerous working groups that are focused in bringing forward agricultural, biotech, industry 4.0 and biopharma products and capabilities to sustain global health and emerging infectious disease threats. AH&HA has launched with a handful of organizations that have agreed to sign on as founding collaborators. It is imperative that Next-Generation Healthcare development methods are aggregated and coupled with a secure investment structure to provide a sustainable healthcare development and deployment model.
The Ultimate Fan, TUF Inc., (TUF), A Global Sports, Entertainment, Business & Real Estate Development Company was created by athletes and entertainers, to give back to the people, community and the Fans that supported them. Our team encompasses Power Players, Literally who have operated on both sides of the Sports, Entertainment, Political, Real Estate and Business aisles while maintaining enduring relationships rooted in the community.By building healthy communities into every phase of the real estate process, we transform social responsibility into lasting economic vitality that benefits the populations we serve. We are devoted to the value delivered through the shared advantage approach to our business. These values complement the UN’s Sustainable Development Goals (SDGs).TUF recognizes the power of uniting private and public enterprises in a single corporate structure to spur business and economic growth around the world to attain the SDG’s. Over the next decade, the potential impact on the global economy — as enterprise and real estate developers, producers, entrepreneurs, employees and consumers — will be at least as significant as that of China and India.
Our vision is to improve patient care using integrated approaches involving laboratory models, mathematical models and machine-learning/Al methods to reduce time to bringing new therapies to market and to optimize treatments for patients after regulatory approval. Our tools include quantitative wet laboratory models made of human-tissue, non-linear dynamical systems, and non-linear mathematical models, which we wrote from scratch and coded, for drug discovery development.Our physician dominated team uses clinical and pathophysiologic know-how, the mathematics of topology and morphism mapping and category theory, to map disease response from the preclinical models to patients, so that readouts in our preclinical models will give precise rates of responses expected in patients, not just in terms of how many patients respond to therapy, but how fast, and the optimal duration of such therapy, and the doses to minimize failure and resistance to therapy. Thus, we can forecast clinical responses in early preclinical development, and then design adaptive clinical trials de novo, including the biomarkers of therapeutic response, duration of therapy, thereby de-risking time (decades), money (millions), and clinical trial patients’ lives (unquantifiable). We also design combination therapy regimens using factorial design to find best companion drugs and doses for therapeutics. Our motto summarizes it all. Quantify. Predict. Cure.
Avril Biopharma is a full-service biologic contract development manufacturing organization (CDMO) leveraging novel and proprietary technologies to translate medicines (including biologics, vaccines, and gene therapies) from discovery lab to the bedside at low cost.The rational approach to protein design and expression can make the difference between a rapid, low-cost project with definitive results versus a long ambiguous effort of trial and error. When it comes to making a personalized product for one cancer patient, time is everything. We apply our Structural Genetics™ software tools for an integrated use of genomics, molecular biology, and manufacturing quality assurance.Rapid vaccine development for responding to emerging diseases, pandemics or bioterrorism is an area of high focus at the moment. Structural Genetics™ allows epidemiological, clinical and immunogenetic knowledge to be integrated in the design of the best possible vaccine products, while our AdCEV™/Egg manufacturing platform easily scales to any required level – saving lives, money, and time. Avril Biopharma can design and manufacture bespoke, gene-based synthetic biology products. Our nanotechnologies and business model are focused on simplifying manufacturing for nextgeneration medicines so that they are affordable to the widest number of people. We are developing technologies and partnerships to make complex, custom-made, medicines as easily accessible as ordering from the local pharmacy.
Trocar Pharma and its scientists have created a tissue-targeted, platform technology focused on allowing humans to survive in the harsh environment of outer space while simultaneously utilizing these same technologies to increase human longevity on Earth. Trocar's platform technology uniquely targets intercellular reactive oxygen species (ROS) with in vivo studies confirming the efficacy of our therapeutics in regenerating stem cells and increasing life span.With over 50% of all deaths attributable to inflammation-related diseases and the overproduction of ROS leading to oxidative stress and chronic inflammation, our platform technology has a myriad of use cases. Trocar's three-prong therapeutic strategy is focused on: 1. Radiation mitigation & protection (on Earth & outside LEO) 2. Oncology 3. Chronic and degenerative diseases
Kamflex – TUF is the only certified minority owned robotic system integration and conveyor manufacturing company in the United States and around the world. Our team of robotic, mechanical, electrical engineers, product and business developers have over 100 years of combined experience. Our partnerships with industry leaders UPS, Mettler Toledo and Fanuc Robotics ensures our customers with the best automation solutions.Since 1974, we’ve provided TUF solutions for 3rd party logistics, aerospace, automotive, Ecommerce, food and beverage, military, package delivery, co-packing, product design and development and pharmaceutical industries with a single source for durable, low maintenance, and compliant conveyor, robotic, assembly, material handling and packaging solutions that are fully integrated into their process.With TUF we are able to drive the entire process from start to finish. From development to engineering, to the design and construction of a facility, TUF gives our customers more competitive financing options that drive costs down and ultimately, provide quicker occupancy of their facility. In addition, TUF will also manage and operate, provide maintenance, supply and distribution, health, and safety, emergency response, human resources, security, information technology and other infrastructural support.
Level 42 AI is an early-stage digital diagnostics intelligence company with device (proprietary sensors and hardware), algorithm (firmware, software and ML/AI), and cloud data solutions. The world needs fast, accurate, non-invasive, and readily scalable screening tests that generate early and frequent health, safety, and security actionable insights to improve diagnostics and support self-directed care.Incumbent diagnostic tools cannot identify and autonomously screen multiple pre-symptomatic illnesses such as pulmonary disease, heart failure, carotid stenosis, aortic aneurysm, early-stage cancers, etc. Level 42 AI rapid and accurate software-as-device solutions harvest data currently ignored or discarded by clinical instrumentation for interpretation by transparent AI/ML algorithms. We deliver tunable AI-enabled solutions that provide equitable, accurate, early disease detection, diagnostic and monitoring super-powers to make the world healthier
A GLOBAL HEALTH & HUMAN ADVANCEMENT CORPORATION
YOU JUST HAD ANOTHER AH & HA MOMENT
A MOMENT OF SUDDEN
INSIGHT AND DISCOVERY!
Copyright © 2023 Advanced Health & Human Advancement – All Rights Reserved.